Comparison of various menopausal symptoms and risk factor analysis in Korean women according to stage of menopause
Front Behav Neurosci 11:9
Ziegler D
As mentioned before, there is current clinical interest in using low dose estradiol therapy to treat antihormone resistant breast cancer [24] however only a minimal 30% of patients respond to this therapeutic strategy
The Precision Peptide Genetic Test ($99 add-on after your first month of treatment) examines 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)all of which affect inflammatory response, pain sensitivity, and weight loss speed
However, because there is limited clinical research evaluating glycine together with tirzepatide , the benefits of this combination remain uncertain